🇺🇸 FDA
Patent

US 8338105

Method of diagnosing poor survival prognosis colon cancer using miR-203

granted A61PA61P1/04A61P35/00

Quick answer

US patent 8338105 (Method of diagnosing poor survival prognosis colon cancer using miR-203) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, National Institute of Health, Office of Technology Tansfer expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Department of Health and Human Services, National Institute of Health, Office of Technology Tansfer
Grant date
Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/04, A61P35/00